TAREZPO Trademark

Trademark Overview


On Tuesday, October 5, 2021, a trademark application was filed for TAREZPO with the United States Patent and Trademark Office. The USPTO has given the TAREZPO trademark a serial number of 97060802. The federal status of this trademark filing is REGISTERED as of Tuesday, October 25, 2022. This trademark is owned by Glaxo Group Limited. The TAREZPO trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
tarezpo

General Information


Serial Number97060802
Word MarkTAREZPO
Filing DateTuesday, October 5, 2021
Status700 - REGISTERED
Status DateTuesday, October 25, 2022
Registration Number6884730
Registration DateTuesday, October 25, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 9, 2022

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Thursday, November 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 25, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 25, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 9, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 25, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 25, 2022NON-FINAL ACTION E-MAILED
Saturday, June 25, 2022NON-FINAL ACTION WRITTEN
Thursday, June 23, 2022ASSIGNED TO EXAMINER
Friday, October 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 8, 2021NEW APPLICATION ENTERED